Suchergebnisse - "Grødeland, Gunnveig"

PubPharm (19)

1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

enthalten in: Nature communications | 2024

von Hinke, D. | Anderson, A. | Katta, K. | +7

2

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients

enthalten in: EBioMedicine | 2023

von Kared, H. | Alirezaylavasani, A. | Lund, K. | +14

3

Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza

enthalten in: Journal of virology | 2023

von Tjärnhage, E. | Brown, D. | Bogen, B. | +2

4

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study

enthalten in: BMC medicine | 2022

von Christensen, I. | Jyssum, I. | Tveter, A. | +16

5

Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Syversen, S. | Jyssum, I. | Tveter, A. | +19

6

Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses

enthalten in: Cell reports | 2022

von Hinke, D. | Andersen, T. | Gopalakrishnan, R. | +6

7

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity

enthalten in: Frontiers in immunology | 2022

von Søraas, A. | Grødeland, G. | Granerud, B. | +29

ErratumIn: Front Immunol. 2023 Jul 12;14:1249100. - PMID 37503347

8

SARS-CoV-2 neutralising antibody testing in Europe : towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2021

von Nguyen, D. | Simmonds, P. | Steenhuis, M. | +29

9

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection

enthalten in: Frontiers in immunology | 2021

von Zhou, F. | Hansen, L. | Pedersen, G. | +2

10

Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs

enthalten in: Vaccine | 2020

von Grodeland, G. | Fossum, E. | Bogen, B.